The antifibrotic effect of novel heart failure pharmacotherapies in myocardial samples of patients undergoing heart transplantation

Back

ESC2025 Premium Access

The antifibrotic effect of novel heart failure pharmacotherapies in myocardial samples of patients undergoing heart transplantation

Session: Evolving strategies in heart failure management

Topic: Pharmacotherapy

Speaker: Doctor D. Nagy (Budapest, HU)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor David Nagy

Semmelweis University Heart and Vascular Center, Budapest (Hungary)

0 follower

5 more presentations in this session

Integrated multi-omic response to heart failure reverse remodeling with left ventricular assist device

Speaker: Doctor X. Xu (Beijing, CN)

Impact of coronary revascularisation in patients undergoing cardiovascular magnetic resonance for viability assessment

Speaker: Doctor A. Lequipar (Paris, FR)

Assessing impact of home-based digital cardiac rehabilitation on readmissions and patient outcomes following step-down from the acute heart failure virtual ward

Speaker: Doctor D. Duvva (Liverpool, GB) Doctor R. Sankaranarayanan (Liverpool, GB)

Impact of empagliflozin on quality-of-life in real-world patients with heart failure: insights from the multinational Emp-Activity study

Speaker: Professor A. Tomaszuk-Kazberuk (Bialystok, PL)

MAGGIC in the machine: unveiling the predictive value of a conventional risk score in the ultra-long LVAD phenotype. Insights from the STELLAR register.

Speaker: Doctor C. Velasquez-Silva (Bad Oeynhausen, DE)

Access the full session

Evolving strategies in heart failure management

Speakers: Doctor D. Nagy, Doctor X. Xu, Doctor A. Lequipar, Doctor D. Duvva, Doctor R. Sankaranarayanan...

Access

Video

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources